Last updated: August 7, 2025
Introduction
China Patent CN105792828 pertains to innovations in the pharmaceutical domain, specifically targeting a novel drug formulation or method. As the Chinese patent system increasingly aligns with international standards, understanding the scope, claims, and patent landscape of CN105792828 provides valuable insights for industry stakeholders, including R&D firms, generic manufacturers, and patent strategists.
This analysis explores the patent's technical scope, the intricacies of its claims, its position within the current patent landscape, and strategic implications for the broader pharmaceutical market in China.
Overview of Patent CN105792828
Application and Grant Timeline
Filed: August 27, 2015
Granted: February 3, 2017
Title (translated): "A pharmaceutical composition and its preparation method"
Primary Focus:
The patent centers on a specific formulation or preparation process, potentially involving active pharmaceutical ingredients (APIs), excipients, and stability or bioavailability enhancements.
Technical Field:
The patent belongs to the pharmaceutical formulations sector, emphasizing drug stability, bioavailability, or controlled-release systems.
Scope of the Patent
1. Thematic and Technical Scope
The patent’s scope encompasses pharmaceutical compositions that leverage specific combinations, formulations, or manufacturing methods. It aims at improving parameters such as drug efficacy, stability, absorption, or patient compliance.
Core Innovations May Include:
- Novel mixtures of APIs with excipients
- Innovative release mechanisms (e.g., controlled-release matrices)
- Enhanced stability formulations for sensitive drugs
The exact scope depends on the breadth of claims, which specify the claims' breadth and limitations.
2. Geographical Scope
As a Chinese national patent, CN105792828 is enforceable within China. While it can be a stepping stone toward international patent applications under the Patent Cooperation Treaty (PCT), without further national filings, its legal scope remains geographically confined.
3. Legal Scope
The patent’s enforceable scope depends heavily on its claims, which define the legal boundary of the invention. Broad claims may cover a wide array of formulations, while narrow claims focus on specific embodiments.
Analysis of the Claims
1. Types of Claims
The patent likely contains a mix of independent and dependent claims:
- Independent Claims: Cover the core invention—e.g., a pharmaceutical composition with specific ingredients and a preparation method.
- Dependent Claims: Refine or specify particular embodiments—e.g., particular ratios of components, process conditions, or additive elements.
2. Claim Scope and Breadth
- If the independent claims are broad, encompassing a wide class of formulations, competitors must design around these claims or seek design-arounds.
- Narrow claims限定 specific components or methods, offering limited freedom to competitors but stronger protection for specific embodiments.
3. Claim Language and Limitations
Effective claims should balance breadth with specificity. For example, a claim such as:
"A pharmaceutical composition comprising: active ingredient A, excipient B, and stabilizer C, wherein the composition exhibits enhanced bioavailability."
is specific but provides room for variations.
4. Novelty and Inventive Step
Given the patent's grant status, the claims sufficiently distinguish over prior art, possibly through:
- A unique combination of known components
- A novel preparation process that enhances drug stability or bioavailability
Thorough prior art searches would have validated these aspects during prosecution.
Patent Landscape Context
1. Related Patents and Prior Art
The patent landscape includes:
- Prior Art in Drug Formulations: Numerous Chinese patents address drug delivery systems, controlled release, and stability (e.g., CN102736782, CN106415615).
- Related International Patents: Similar formulations may exist in the US and EP, with patent families covering comparable drug delivery innovations.
2. Patent Family and Litigation Potential
- The patent may belong to a family with filings in other jurisdictions, particularly if the applicant aims international protection.
- Its scope could be challenged if prior art publication predates the filing, especially for broad claims.
3. Competitor Landscape
Major pharmaceutical companies active in China, e.g., Sinopharm, CSPC, or local generics firms, often seek patents in similar domains, leading to a crowded patent landscape.
Strategic Implications
1. Enforcement and Commercialization
- The patent's enforceability depends on the maturity and clarity of its claims.
- Effective enforcement can prevent generic entry for key formulations, safeguarding market share.
2. Patent Expiry and Lifecycle Management
- As the patent was filed in 2015 and granted in 2017, it will typically expire around 2035, assuming a 20-year term.
- Innovators should explore supplementary protection strategies or patent extensions for valuable formulations.
3. R&D and Patent Strategy
- Innovators can develop derivative works with modified claims to extend protection.
- Filing secondary patents around improvements or new indications can preserve competitive advantage.
Conclusion
China patent CN105792828 represents a strategically significant patent within the pharmaceutical formulation domain. Its scope, driven by its claims, likely covers a specific combination or process that offers therapeutic or stability advantages. The patent landscape indicates a competitive environment with numerous similar innovations, underscoring the importance of patent claim clarity and ongoing portfolio management.
For industry stakeholders, leveraging this patent involves diligent patent monitoring, ensuring freedom-to-operate, and capitalizing on the protected formulation. The patent landscape also emphasizes the need for continual innovation and strategic patent filings to maintain market edge.
Key Takeaways
- Scope and Claims: The patent likely covers specific drug formulations and processes; broad claims enhance market protection but can invite scrutiny.
- Enforceability: Well-defined claims with clear novelty support robust enforcement in China.
- Patent Landscape: A heavily populated field necessitates strategic differentiation, including filing evolving patents.
- Market Implication: The patent provides a competitive moat, protecting core formulations for its term.
- Strategic Recommendations: Innovators should monitor similar patents, consider international filings, and develop follow-up patents to extend exclusivity.
FAQs
Q1: How does the scope of CN105792828 compare to similar patents in the field?
A1: The scope depends on the breadth of its claims. If broad, it covers extensive formulations, but many competitors have similar patents, creating a competitive landscape. Specificity in claims often helps define a clear protection boundary.
Q2: Can this patent be challenged or invalidated?
A2: Yes. Potential grounds include discovering prior art that predates the filing date or demonstrating that the claims lack inventive step or novelty, particularly if new publications or products emerge.
Q3: What strategies can companies employ to navigate the patent landscape around CN105792828?
A3: Companies should conduct thorough freedom-to-operate analyses, consider patent circumvention, and file their own patents on alternative formulations or improvements related to this technology.
Q4: Does this patent cover only specific formulations, or is it broadly applicable?
A4: The scope hinges on claim language. Narrow claims cover specific embodiments; broad claims potentially cover entire classes of formulations. A detailed claim analysis reveals the exact coverage.
Q5: What is the importance of patent landscape analysis in pharmaceutical R&D?
A5: It helps identify patent gaps and density, informs R&D direction, mitigates infringement risks, and guides strategic patent filings to maximize market protection.
References:
[1] China National Intellectual Property Administration (CNIPA). Official Patent Database.
[2] Patent CN105792828.
[3] Related patent filings and technical disclosures in prior art databases.
